Log in
Donate
Search
Close this search box.

Clinical Trial: ALLIANCE A071702

ALLIANCE A071702

Status: Temporarily Closed

NCT#04145115

A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma

A071702 is temporarily closed to new patient pre-registration (Step 0), effective December 12, 2023.

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved